Published on in Vol 11, No 9 (2022): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40025, first published
.

Journals
- Loeffler D, Ihara M. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems. Journal of Alzheimer's Disease 2024;100(2):379 View
- Tong S, Greenberg J, Marini C, Seixas A, Doan L, Osorio R, Thawani S. Disordered Sleep and Painful Diabetic Neuropathy (PDN): a Review of the Literature on Pathophysiology, Pharmacologic and Nonpharmacologic Treatment Options, and Future Directions. Current Sleep Medicine Reports 2025;11(1) View
- Gilron I, Elkerdawy H, Tu D, Holden R, Moulin D, Duggan S, Milev R. Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trial. Pain 2025;166(11):2541 View
- Jang S, Choi J, Lim H, Kim H, Yoo Y. Comparative Analysis of Melatonin and Polydeoxyribonucleotide: Possible Benefits of Co-Treatment Effects and Potential Synergistic Applicability. International Journal of Molecular Sciences 2025;26(12):5703 View
- Kuthati Y, Rao V, Mende L, Wong C. Therapeutic potential of melatonin in management of diabetic mellitus and diabetic neuropathic pain: Underlying mechanisms, challenges and future perspectives. Journal of the Formosan Medical Association 2025 View
- Garikipati S, Pratigudupu R, David J, Pandi S, Badugu V, Chunduru P. Melatonin and Alprazolam as anxiolytic agents in Minor oral surgical procedures – A Comparative study. Annals of Maxillofacial Surgery 2025 View
